Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Article | By Abdul Ally and Amy Hendricks, Thermo Fisher Scientific As sponsors focus on maintaining the temperature range required for cell and gene therapies they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
Contributed Commentary By Mitch Finer July 23, 2020 | The last three years we have witnessed an exponential expansion of the cell and gene therapy (CGT) space, both in the number of cell and gene therapies approved or in development, and the real and projected values of the market. This growth is rapidly changing the way we think about what medicines are. More importantly, I believe it’s changing the way we must think about making medicines.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.